$CERE+136%

$CERE, Cerevel Therapeutics who is a company dedicated to unraveling the mysteries of the brain and  treat neuroscience diseases, announced today that is has commenced an underwritten public offering of 14.000.000 shares of its common stock and additional  2.100.000 options for 30 days.

We often see this kind of move when private’s placement are close like this.

Here is the detail of the news.

Here is the graph of the day:

Here is a 30-day overview: